Multiple Myeloma and Benign Monoclonal Gammopathy: Differentiation by Immunofluorescence of Lymphocytes

  1. FOLKE D. LINDSTRÖM, M.D.;
  2. WILLIAM R. HARDY, M.D.;
  3. BETTY J. EBERLE, Ph.D.; and
  4. RALPH C. WILLIAMS, JR., M.D.
  1. Albuquerque, New Mexico

    Abstract

    The proportions of T and B cells among peripheral blood lymphocytes were studied in 46 patients with plasma cell myeloma and in 14 patients with benign monoclonal gammopathy. Significant lowering (P < 0.001) of percentages of B cells having normal surface Ig was found in the myeloma group, whereas the patients with benign M-components showed normal proportions of B cells. Mean percentage of total B cells in myeloma patients was 10.3% ± 6.9%, whereas mean B-cell value in benign monoclonal gammopathy was 21.4% ± 11.7%. Normal B-cell values were 22.9% ± 7.1%. Myeloma patients in remission tended to have normal proportions of B cells. Individually specific or idiotypic M-component antigenic Ig markers were present in relatively high percentages in peripheral blood lymphocytes from two patients with myeloma, whereas the reverse was true in a patient with a benign M-component. There was some overlap in total B-cell values between patients with established myeloma and those with benign monoclonal gammopathy.

    Article and Author Information

    • ▸From the Department of Medicine, Bernalillo County Medical Center, University of New Mexico School of Medicine, Albuquerque, New Mexico.

    • Grant support: AM 13690-04 and AM 13824-04, U.S. Public Health Service; and a grant from the New Mexico Arthritis Foundation.

    • ▸Requests for reprints should be addressed to Ralph C. Williams, Jr., M.D., 5th floor, Department of Medicine, Bernalillo County Medical Center, Albuquerque, NM 87106.

      • Received January 2, 1973.
      • Accepted March 15, 1973.
    « Previous | Next Article »Table of Contents